You are here

  • Home
  • Archive
  • Volume 65, Issue Suppl 1
  • PTH-083 Cost-Effectiveness of Vedolizumab Compared with Conventional Therapy for Treatment of Moderately-to-Severely Active Ulcerative Colitis in The United Kingdom

Article metrics

Article menu
Download PDFPDF
BSG 2016
PTH-083 Cost-Effectiveness of Vedolizumab Compared with Conventional Therapy for Treatment of Moderately-to-Severely Active Ulcerative Colitis in The United Kingdom

 

Online download statistics by month:

Online download statistics by month: September 2016 to March 2024

AbstractFullPdf
Sep 2016400
Oct 2016802
Nov 201617021
Dec 20161902
Jan 20171801
Feb 20171902
Mar 2017600
Apr 2017200
May 2017900
Jun 20171601
Jul 20171200
Aug 20173000
Sep 20171602
Oct 20171200
Nov 20171400
Dec 20171202
Jan 20181000
Feb 2018600
Mar 2018800
Apr 20182000
May 20181000
Jun 20182000
Jul 20181400
Aug 20181001
Sep 20181400
Oct 2018600
Nov 2018800
Dec 2018400
Jan 2019400
Feb 2019200
Apr 20191800
May 2019700
Jun 20191300
Jul 20191800
Aug 20191000
Sep 2019200
Oct 20191000
Nov 2019200
Dec 2019500
Jan 20201601
Jun 2020401
Jul 2020400
Aug 2020801
Sep 20203200
Oct 2020400
Nov 2020200
Dec 2020800
Jan 2021300
Feb 2021602
Mar 2021600
Nov 20211400
Dec 2021400
Jan 2022800
Feb 2022200
Apr 2022500
May 2022800
Jun 2022500
Jul 20221001
Aug 2022400
Sep 2022402
Oct 20222200
Nov 20221000
Dec 20221200
Jan 2023800
Feb 2023600
Mar 2023600
Apr 20232301
May 20231800
Jun 2023201
Jul 2023600
Aug 2023400
Sep 2023800
Oct 2023400
Nov 2023400
Dec 2023800
Jan 2024200
Feb 2024600
Mar 2024200
Total743044